Ji L, Jiang H, Cheng Z, Qiu W, Liao L, Zhang Y, et al
Glucagon-like peptide 1 (GLP-1) agonists have become widely available
#CardiovascularDrugs #Cardiology #HeartHealth #PharmaceuticalIndustry #CardiovascularDisease #PharmaInnovation To view or add a comment, sign in : : The biosimilars market is expected to reach USD 72.29 billion by 2035 from USD 35.04 billion in 2025, at a CAGR of 7.5% during the forecast period
Our nutrition tools help you: Track protein intake , crucial for preserving muscle mass during weight loss Monitor hydration , especially important as dehydration can worsen GLP-1 side effects Balance macronutrients to ensure youre getting adequate nutrition despite eating less Identify trigger foods that may worsen nausea or other side effects Plan smaller, more frequent meals that may be better tolerated Our food journal connects directly with your symptom tracker, helping you identify connections between what you eat and how you feel information that proves invaluable for making dietary adjustments
